Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with inflammatory bowel disease (IBD) have been associated with reduced bacterial diversity and a decline in butyrate-producing bacteria such as Faecalibacterium prausnitzii, indicating the importance of gut dysbiosis in IBD [138, 139].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [139]
In the citing paper
“mucosa-associated microbes preferentially regulate host homeostasis, as is evident in the induction of T-cell immune responses, as well as maintaining serotonin biosynthesis from dietary tryptophan in the mucosa.28, 29, 30, 31, 32, 33”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [28]
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“In our study, we found that the proportions of detected mucosa-associated bacteria in healthy gastrointestinal tracts were uniformly distributed along the colon, which was in accordance with the findings from a previous study (23, 24).”
ResultFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“leptum group was strikingly low in mucosa-associated microbiotas (40, 41).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“One study suggested that Faecalibacterium prausnitzii prevents 2,4,6-trinitrobenzenesulfonic acid (TNBS)induced colitis (16).”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Cited by
Items 201–300 of 510
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease
Bellini, G., Benvenuti, L., Ippolito, C., Frosini, D., Segnani, C., Rettura, F., Pancetti, A., Bertani, L., D’Antongiovanni, V., Palermo, G., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15607 · Cited by 41
Current, experimental, and future treatments in inflammatory bowel disease: a clinical review
Hvas, C. L., Bendix, M., Dige, A. K., Dahlerup, J. F., & Agnholt, J. S. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2018.1469144 · Cited by 42
“deficient production of short chain fatty acids (SCFAs) [14]”
BackgroundMicrobiota in Gut, Oral Cavity, and Mitral Valves Are Associated With Rheumatic Heart Disease
Shi, X., Chen, B., Lin, W.-Z., Li, Y., Wang, Y., Liu, Y., Huang, J., Zhang, W., Ma, X., Shao, S., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.643092 · Cited by 40
“Similarly, previous studies have demonstrated an increase of Bifidobacterium or Eubacterium in patients with inflammatory bowel disease (Wang et al., 2013) or systemic lupus erythematosus (He et al.”
ResultSchäffler, H., Herlemann, D. P. R., Alberts, C., Kaschitzki, A., Bodammer, P., Bannert, K., Köller, T., Warnke, P., Kreikemeyer, B., & Lamprecht, G. (2016) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12411 · Cited by 39
Peng, J., Gong, H., Lyu, X., Liu, Y., Li, S., Tan, S., Dong, L., & Zhang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1127041 · Cited by 42
“Changes in the microbiota of those suffering from various diseases have been associated with reduced diversity of bacteria and the amount of SCFAs in the feces (Machiels et al., 2014; Wang et al., 2014).”
BackgroundZachos, K. A., Gamboa, J. A., Dewji, A. S., Lee, J., Brijbassi, S., & Andreazza, A. C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1428242 · Cited by 38
Comparison of sampling methods in assessing the microbiome from patients with ulcerative colitis
Kim, D., Jung, J.-Y., Oh, H., Jee, S.-R., Park, S. J., Lee, S., Yoon, J.-S., Yu, S. J., Yoon, I.-C., & Lee, H. S. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-01975-3 · Cited by 36
“And as the effect of FMT for IBD treatment has been reported, the need for research on the *Correspondence: hslee@paik.ac.kr †Dan Kim and Jun‑Young Jung have contributed equally to this work 1 Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital, 75 Bokji‑ro, Busanjin‑gu, Busan 473…”
BackgroundInfluentialHernandez‐Sanabria, E., Heiremans, E., Calatayud, M., Props, R., Leclercq, L., Snoeys, J., & de Wiele, T. V. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0119-0 · Cited by 36
What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
Łykowska‐Szuber, L., Rychter, A. M., Dudek, M., Ratajczak, A. E., Szymczak‐Tomczak, A., Zawada, A. E., Eder, P., Lesiak, M., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2021) · Nutrients · doi:10.3390/nu13082661 · Cited by 38
“, Faecalibacterium prausnitzii and Roseburia intestinalis) in the mucosa [71].”
BackgroundShort chain fatty acids (SCFAs) improves TNBS-induced colitis in zebrafish
Morales, C., do Amaral, M. A., Xavier, I. K., Padovani, B. N., Paredes, L. C., Takiishi, T., Lopes‐Ferreira, M., Lima, C., Colombo, A., & Câmara, N. O. S. (2021) · Current Research in Immunology · doi:10.1016/j.crimmu.2021.08.003 · Cited by 41
Hsu, C., Ghannoum, M. A., Cominelli, F., & Martino, L. D. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac156 · Cited by 35
Pu, W., Zhang, H., Zhang, T., Guo, X., Wang, X., & Tang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1004756 · Cited by 36
Self-citationYang, M., Wang, J., Shin, J., Lee, D., Lee, S., Seo, J., Shin, J., Nam, Y., Kim, H., & Sun, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220044 · Cited by 47
“prausnitzii was decreased in the patients with inflammatory bowel disease as compared to healthy control (92).”
BackgroundKim, D. M., Liu, J., Whitmore, M. A., Tobin, I., Zhao, Z., & Zhang, G. (2024) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-024-00995-9 · Cited by 41
“Interestingly, a similar enrichment of lactobacilli and bifidobacteria is observed in the colon of patients with inflammatory bowel disease [52].”
BackgroundGut microbiota therapy in gastrointestinal diseases
Ullah, H., Arbab, S., Chang, C., Bibi, S., Muhammad, N., Rehman, S. U., Suleman, S., Ullah, I., Hassan, I. U., Tian, Y., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1514636 · Cited by 42
The human gut microbiome of Latin America populations: a landscape to be discovered
Magne, F., O’Ryan, M. L., Vidal, R. M., & Farfán, M. J. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000300 · Cited by 38
“Bacterial groups involved in obesity and inflammatory bowel diseases Diseases Bacterial groups Increased Decreased Obesity Bacteroidetes/Firmicutes ratio [7,8] [9–11] Lactobacillus [11] Methanobacteriales [7,8,12] Inflammatory bowel disease Bacteroidetes IBD [13] IBD [14] CD [15] Bifidobacteria IBD [16] CD [14] CD [13…”
BackgroundNi, Y., Mu, C., He, X., Zheng, K., Guo, H., & Zhu, W. (2018) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2018.01036 · Cited by 41
“An increase in Lactobacillus and a decrease in butyrate-producing bacteria have been also observed in type 2 diabetes patients (23,24), inflammatory bowel disease patients (25), and highfat diet-induced fatty liver mice (26).”
BackgroundZhang, Y., Mu, T., Yang, Y., Zhang, J., Ren, F., & Wu, Z. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab250 · Cited by 35
Hart, L., Verburgt, C. M., Wine, E., Zachos, M., Poppen, A., Chavannes, M., Limbergen, J. V., & Pai, N. (2021) · Nutrients · doi:10.3390/nu14010004 · Cited by 36
“Further research applying a common, standardized methodology will be required to further describe the role of EEN as maintenance therapy [98].”
BackgroundMethodGrouls, M., Janssen, A. W. F., Duivenvoorde, L. P. M., Hooiveld, G. J. E. J., Bouwmeester, H., & van der Zande, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-17296-8 · Cited by 36
Scaldaferri, F., Pecere, S., Petito, V., Zambrano, D., Fiore, L., Lopetuso, L. R., Schiavoni, E., Bruno, G., Gerardi, V., Laterza, L., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.12.040 · Cited by 35
Tyakht, A., Manolov, A. I., Kanygina, A. V., Ischenko, D. S., Kovarsky, B. A., Popenko, A., Pavlenko, A. V., Elizarova, A., Rakitina, D. V., Baikova, I. P., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-5306-5 · Cited by 36
“The increased levels of Lactobacillus rhamnosus (in both stool and ileal samples from one patient, 53 and 8%) and Bifidobacterium breve (1 stool sample, 4%) were likely due to the intake of probiotic or dairy products; however, certain studies have shown an increase in the respective genera in microbiota from IBD pati…”
Gut microbiota in hypertensive patients with versus without obstructive sleep apnea
Lu, D., Xu, S., Dai, P., Wu, L., Zhang, H., & Zhou, B. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14598 · Cited by 32
Mucosal cancer-associated microbes and anastomotic leakage after resection of colorectal carcinoma
Mima, K., Sakamoto, Y., Kosumi, K., Ogata, Y., Miyake, K., Hiyoshi, Y., Ishimoto, T., Iwatsuki, M., Baba, Y., Iwagami, S., et al. (2019) · Surgical Oncology · doi:10.1016/j.suronc.2019.11.005 · Cited by 36
Ambrożkiewicz, F., Karczmarski, J., Kulecka, M., Paziewska, A., Niemira, M., Żeber‐Lubecka, N., Zagórowicz, E., Kretowski, A. J., & Ostrowski, J. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01444-3 · Cited by 33
“The abudance of Bacteroidetes were higher, whereas the amounts of Firmicutes were lower, in stool samples from CD patients than from controls.”
BackgroundInfluentialBodden, C., Pang, T. Y., Feng, Y., Mridha, F., Kong, G., Li, S., Watt, M. J., Reichelt, A. C., & Hannan, A. J. (2021) · The FASEB Journal · doi:10.1096/fj.202100920rr · Cited by 34
Salivary microbiome of an urban Indian cohort and patterns linked to subclinical inflammation
Acharya, A., Chan, Y., Kheur, S. M., Kheur, M. G., Gopalakrishnan, D., Watt, R., & Mattheos, N. (2017) · Oral Diseases · doi:10.1111/odi.12676 · Cited by 35
Inflammatory Diseases of the Gut
Rohr, M., Narasimhulu, C. A., Sharma, D., Doomra, M., Riad, A., Naser, S. A., & Parthasarathy, S. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0138 · Cited by 39
The role of gut microbiota in intestinal and liver diseases
Hrncir, T., Hrncirova, L., Kverka, M., & Tlaskalová‐Hogenová, H. (2018) · Laboratory Animals · doi:10.1177/0023677218818605 · Cited by 33
Chen, G., Zhang, Y., Wang, W., Ji, X., Meng, F., Xu, P., Yang, N., Ye, F., & Bo, X. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4624 · Cited by 29
Self-citationWang, D., Du, Y., Wang, S., You, Z., & Liu, Y. (2021) · Animal Science Journal · doi:10.1111/asj.13584 · Cited by 28
Jiang, X., Jiang, Z., Cheng, Q., Sun, W., Jiang, M., & Sun, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1000563 · Cited by 37
Chen, S.-F., Ren, Z., Huo, Y., Yang, W., Peng, L., Lv, H., Nie, L., Wei, H., & Wan, C. (2022) · Food Research International · doi:10.1016/j.foodres.2022.112010 · Cited by 31
Tian, S., Paudel, D., Hao, F., Neupane, R., Castro, R., Patterson, A. D., Tiwari, A. K., Prabhu, K. S., & Singh, V. (2023) · Cancer Reports · doi:10.1002/cnr2.1863 · Cited by 33
Nieva, C., Pryor, J., Williams, G. M., Hoedt, E. C., Burns, G. L., Eslick, G. D., Talley, N. J., Duncanson, K., & Keely, S. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad204 · Cited by 35
“…bacteria within the dominant Firmicutes phylum, such as Faecalibacterium , Clostridium, and Blautia , consistently found to be significantly depleted in the gut of IBD patients, 8,64 indicating that diet is imperative in shifting the intestinal microbial dysbiosis towards a balanced community.”
BackgroundLopetuso, L. R., Napoli, M., Rizzatti, G., & Gasbarrini, A. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1483333 · Cited by 31
Jiao, C., Zhang, Q., Yang, M., Ma, J., Zhao, X., Tang, N., Dai, M., Li, Q., Jiang, Z., Huang, X. H., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115145 · Cited by 33
Shin, S. Y., Kim, Y., Kim, W.-S., Moon, J. M., Lee, K., Jung, S.-A., Park, H., Huh, E. Y., Kim, B. C., Lee, S. C., et al. (2022) · Intestinal Research · doi:10.5217/ir.2021.00168 · Cited by 30
“As a result, the use of Bifidobacterium as a probiotic for IBD patients during the active disease status requires caution.(48) In the present study, a higher abundance of B.”
Zhao, J., Nian, L., Kwok, L. Y., Sun, T., & Zhao, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2955-2 · Cited by 30
“Individuals with IBD [30] and rheumatoid arthritis [31] exhibit a depletion of butyrate producers in their gut.”
BackgroundOptimized tableting for extremely oxygen-sensitive probiotics using direct compression
Allouche, R., Dupont, S., Charriau, A., Gervais, P., Beney, L., & Chambin, O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.010 · Cited by 28
Sadeghi, O., Milajerdi, A., Siadat, S. D., Keshavarz, S. A., Sima, A. R., Vahedi, H., Adibi, P., & Esmaillzadeh, A. (2020) · Trials · doi:10.1186/s13063-020-04523-8 · Cited by 32
“Based on the previous studies, UC patients not only show reduced levels of SCFAs-producing bacteria in intestinal mucosa and feces, but the actual steady-state levels of SCFAs herein also appear to be less than healthy controls [39, 40].”
ResultAriaee, A., Koentgen, S., Wardill, H. R., Hold, G. L., Prestidge, C. A., Armstrong, H., & Joyce, P. M. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100055 · Cited by 31
“68 Despite this, the benefits of XOS are limited by insufficient evidence in clinical IBD studies.”
Li, J., Wang, S., Yan, K., Wang, P., Jiao, J., Wang, Y., Chen, M., Dong, Y., & Zhong, J. (2024) · iMeta · doi:10.1002/imt2.222 · Cited by 26
“Moreover, Lactobacillus , an inflammation ‐ related bacterium, was found to be highly abundant in hypertensive patients with obstructive sleep apnea and inflammatory bowel disease [36, 37].”
BackgroundBiotics and bacterial function: impact on gut and host health
Kandari, A., Al-Odat, M. A., Alzaïd, F., & Scott, K. P. (2024) · The ISME Journal · doi:10.1093/ismejo/wrae226 · Cited by 30
“Forexample,increasedlevelsof Bifidobacterium and Lactobacillus have been observed in patients with active inflammatory bowel disease, possibly due to the reduction of butyrate-producing bacteria [149].”
Khairudin, M. A. S., Jalil, A. M. M., & Hussin, N. (2021) · Gastroenterology Insights · doi:10.3390/gastroent12020018 · Cited by 28
Li, Z., Li, Z., Zhu, L., Dai, N., Sun, G., Peng, L., Wang, X., & Yang, Y. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.778542 · Cited by 28
Self-citationA Personalized Approach to Managing Inflammatory Bowel Disease.
Kingsley, M. J., & Abreu, M. T. (2016) · PubMed · Cited by 33
Robust Microbial Markers for Non-Invasive Inflammatory Bowel Disease Identification
Wingfield, B., Coleman, S., McGinnity, T. M., & Bjourson, A. J. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2831212 · Cited by 27
“1 Clostridiales Ruminococcaceae @[15] 1 Bacteroidales Bacteroidaceae Bacteroides vulgatus @[15] 1 Lactobacillales Lactobacillaceae Pediococcus @[68] 1 Erysipelotrichales Erysipelotrichaceae Erysipelotrichaceae UCG-003 @[15] 0.”
Lactic Acid Bacteria–Gut-Microbiota-Mediated Intervention towards Inflammatory Bowel Disease
Li, D., Liu, Z., Fan, X., Zhao, T., Wen, D., Huang, X., & Li, B. (2024) · Microorganisms · doi:10.3390/microorganisms12091864 · Cited by 30
“[119], Lactobacillus [120], and Bifidobacterium [121].”
Beneficial Effects of Plant Extracts and Bioactive Food Components in Childhood Supplementation
Ullah, H., Filippis, A. D., Baldi, A., Dacrema, M., Esposito, C., Garzarella, E. U., Santarcangelo, C., Tantipongpiradet, A., & Daglia, M. (2021) · Nutrients · doi:10.3390/nu13093157 · Cited by 30
Wu, J., Guo, W., Cui, S., Tang, X., Zhang, Q., Lu, W., Jin, Y. J., Zhao, J., Mao, B., & Chen, W. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12382 · Cited by 29
Park, S., Kim, H., Choi, C. H., Im, J. P., Cha, J. M., Eun, C. S., Kim, T.-O., Kang, S., Bang, K. B., Kim, H. G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061748 · Cited by 25
“The increased levels of Lactobacillus were unlikely due to the intake of probiotic, as we enrolled the patients after discontinuing the probiotics, and certain studies have shown an increase in the Lactobacillus in IBD patients [26,27].”
ResultNami, Y., Ranjbar, M. S., Aval, M. M., & Haghshenas, B. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100496 · Cited by 40
Roy, A., & Lichtiger, S. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000641 · Cited by 23
Microbial butyrate capacity is reduced in inflamed mucosa in patients with ulcerative colitis
Jangi, S., Moyer, J. H., Sandlow, S., Fu, M., Chen, H., Shum, A., Hsia, K., Cersosimo, L. M., Yeliseyev, V., Zhao, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54257-9 · Cited by 27
Disentangling the nutrition-microbiota liaison in inflammatory bowel disease
Florio, M., Crudele, L., Sallustio, F., Moschetta, A., Cariello, M., & Gadaleta, R. M. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101349 · Cited by 23
Chen, X., Zhang, Z., Cui, B., Jiang, A., Tao, H., Shaomin, C., & Liu, Y. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07368 · Cited by 25
Shen, Y., Jiang, Z., Zhong, X., Wang, H., Liu, Y., & Li, X. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153455 · Cited by 22
Emerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Kayama, H., & Takeda, K. (2023) · European Journal of Immunology · doi:10.1002/eji.202249866 · Cited by 22
Martín-Adrados, B., Wculek, S. K., Fernández‐Bravo, S., Torres-Ruiz, R., Valle-Noguera, A., Gómez-Sánchez, M. J., Hernández-Walias, J. C., Ferreira, F. M., Corraliza, A. M., Sancho, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185517 · Cited by 24
“HMGCS2 expression is dependent on its substrate, butyrate (30), and IBD patients generally have a reduction in intestinal butyrate-producing bacteria (31), which could explain the lack of HMGCS2 in the inflamed gut.”
BackgroundNarrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis
Tambovtseva, R. S., ARSLAN, L., Grigoryeva, T., Abdulkhakov, S. R., Doludin, Y. V., Стома, И. О., Rizvanov, A. A., Рифкатовна, М. Р., & Gabdoulkhakova, A. G. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00210-24 · Cited by 28
“For patients active UC, there has been a significant decrease in the proportion of F. prausnitzii and A. muciniphila in the fecal specimens compared with quiescent UC and healthy controls (172, 173, 181).”
Rodriguez, D. M., Hintze, K. J., Rompato, G., Wettere, A. J. V., Ward, R. E., Phatak, S., Neal, C., Armbrust, T., Stewart, E. C., Thomas, A. J., et al. (2022) · Nutrients · doi:10.3390/nu14245270 · Cited by 24
Do, K.-H., Ko, S., Kim, K. B., Seo, K.-W., & Lee, W.-K. (2023) · Microorganisms · doi:10.3390/microorganisms11112750 · Cited by 27
Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis
Cardoneanu, A., Mihai, C., Rezuş, E., Burlui, A., Popa, I. V., & Prelipcean, C. C. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-2823 · Cited by 24
Crosstalk between butyrate oxidation in colonocyte and butyrate-producing bacteria
Park, B., Kim, J. Y., Riffey, O. F., Walsh, T. J., Johnson, J., & Donohoe, D. R. (2024) · iScience · doi:10.1016/j.isci.2024.110853 · Cited by 30
Mohamed, S. S., Abdeltawab, N. F., Wadie, W., Ahmed, L. A., Ammar, R. M., Rabini, S., Abdel-Aziz, H., & Khayyal, M. T. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03337-8 · Cited by 24
Parment, R., Dubois, M., Desrues, L., Mutel, A., Dembélé, K.-P., Belin, N., Tron, L., Guérin, C., Coëffier, M., Compère, V., et al. (2022) · Cancers · doi:10.3390/cancers14184403 · Cited by 25
“5-FU: 5-fluorouracil, L.: Lactobacillus, PCA: principal component analysis, RCSI: relative cluster stability index.”
BackgroundInfluentialLiang, X.-Q., Mai, P.-Y., Qin, H., Li, S., Ou, W.-J., Liang, J., Zhong, J., & Liang, M.-K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.972351 · Cited by 20
Song, M., Wang, C., Yu, M., Deng, D., Liu, Z., Cui, Y., Tian, Z., Rong, T. Z., Li, Z., Ma, X., et al. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12254 · Cited by 19
Zhang, Y., Sun, Y., Liu, Y., Liu, J., Sun, J., Bai, Y., Fan, B., Lu, C., & Wang, F. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105411 · Cited by 22
Tabbaa, O. M., Aboelsoud, M. M., & Mattar, M. C. (2018) · Gastroenterology Research · doi:10.14740/gr1091 · Cited by 22
“Therefore, the gut microbiome has been proposed as a key driver in the immune response seen in IBD and has gained more focus in recent observational studies [12].”
BackgroundFecal transplantation: any real hope for inflammatory bowel disease?
Moayyedi, P. (2016) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000285 · Cited by 24
Cortes, G. M., Marcialis, M. A., Bardanzellu, F., Corrias, A., Fanos, V., & Mussap, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.856165 · Cited by 22
Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research
Zhang, S., Cao, X., & Huang, H. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00051 · Cited by 21
“Researchers discovered that mechanical beadbeating extraction kits produced less total DNA when compared with the enzymatic methods.”
BackgroundUptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
Ota, S., & Sakuraba, H. (2022) · Immuno · doi:10.3390/immuno2040042 · Cited by 26
“The expression of MCT1 in the colon is reportedly decreased in patients with IBD and experimental colitis models [46,47,59].”
BackgroundLi, W., Yi, X., Wu, B., Li, X., Ye, B., Deng, Z., Runa, A., Hu, S., Li, D., Wu, H., et al. (2023) · Fermentation · doi:10.3390/fermentation9090827 · Cited by 30
Relationships between Habitual Polyphenol Consumption and Gut Microbiota in the INCLD Health Cohort
Vita, A. A., Roberts, K. M., Gundersen, A., Farris, Y., Zwickey, H. L., Bradley, R. D., & Weir, T. L. (2024) · Nutrients · doi:10.3390/nu16060773 · Cited by 23
“…in various nephropathies, either being correlated with disease outcomes (e.g., Lachnoclostridium , Bacteroides and Ruminococcus torques group [123]) or their increased abundance observed in diseased individuals (e.g., Enterococcus , Eubacterium ventriosum group , and Lachnoclostridium [124]).”
Wu, Z.-Y., Li, Y., Jiang, M., Sang, L.-X., & Chang, B. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s449335 · Cited by 18
The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings
Tremlett, H. L., & Waubant, E. L. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0574-3 · Cited by 19
Wang, D., You, Z., Du, Y., Zheng, D., Jia, H., & Liu, Y. (2022) · Animals · doi:10.3390/ani12010123 · Cited by 18
OTUD3 prevents ulcerative colitis by inhibiting microbiota-mediated STING activation
Li, B., Sakaguchi, T., Tani, H., Ito, T., Murakami, M., Okumura, R., Kobayashi, M., Okuzaki, D., Motooka, D., Ikeuchi, H., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adm6843 · Cited by 17
Liu, T., Jia, F., Guo, Y., Wang, Q., Zhang, X., Chang, F., & Xie, Y. X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1081591 · Cited by 19
Tanelian, A., Nankova, B. B., Miari, M., & Sabban, E. L. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00590-7 · Cited by 20
Wang, Y., Wymond, B., Tandon, H., & Belobrajdic, D. P. (2024) · Nutrients · doi:10.3390/nu16070989 · Cited by 21
Dynamic response of the intestinal microbiome to Eimeria maxima- induced coccidiosis in chickens
Liu, J., Guo, J., Whitmore, M. A., Tobin, I., Kim, D. M., Zhao, Z., & Zhang, G. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00823-24 · Cited by 18
“Similar enrichment of lactobacilli has been observed in patients with inflammatory bowel disease (17).”
Garrido‐Mesa, J., Algieri, F., Rodríguez‐Nogales, A., Vezza, T., Utrilla, M. P., García, F., Chueca, N., Rodríguez‐Cabezas, M. E., Garrido‐Mesa, N., & Gálvez, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.044 · Cited by 19
Probiotics in inflammatory bowel disease: Does it work?
Silva, N. O. E., Brito, B. B. D., Silva, F. A. F. D., Santos, M. L. C., & Melo, F. F. D. (2020) · World Journal of Meta-Analysis · doi:10.13105/wjma.v8.i2.54 · Cited by 17
Butucel, E., Balta, I., McCleery, D., Marcu, A., Stef, D. S., Peț, I., Callaway, T. R., Ştef, L., & Corcionivoschi, N. (2022) · Biology · doi:10.3390/biology12010057 · Cited by 19
“The endpoint PCR and the RT-PCR were performed as previously described [27].”
MethodAnalysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease
Hu, X., & Yang, F. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/3757763 · Cited by 17
Kiron, V., Hayes, M., & Avni, D. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.09.012 · Cited by 17
Amara, J., Itani, T. M., Hajal, J., Bakhos, J., Saliba, Y., Aboushanab, S. A., Kovaleva, E. G., Farès, N., Mondragón, A. D. C., & Miranda, J. M. (2024) · Nutrients · doi:10.3390/nu16020247 · Cited by 15
“In essence, our research contributes valuable knowledge to the evolving fields of circadian biology and gut health, paving the way for further investigations into clinical applications and preventive strategies.”
BackgroundVacca, M., Sommella, E., Liso, M., Verna, G., Scarano, A., Sila, A., Curlo, M., Mastronardi, M., Petroni, K., Tonelli, C., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2023.9250036 · Cited by 17
Intestinal newborn regulatory B cell antibodies modulate microbiota communities
Gu, Q., Draheim, M., Planchais, C., He, Z., Mu, F., Gong, S., Shen, C., Zhu, H., Zhivaki, D., Shahin, K., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.08.010 · Cited by 17
Jing, W., Gao, X., Han, B.-L., Wei, B., Hu, N., Li, S., Yan, R., & Wang, Y. (2017) · RSC Advances · doi:10.1039/c6ra25448a · Cited by 17
Yoshida, K., Murayama, M. A., Shimizu, K., Tang, C., Katagiri, N., Matsuo, K., Fukai, F., & Iwakura, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.116 · Cited by 16
Zhu, Y., Xiong, Y., Gu, Y., Li, Q., & Liu, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.926039 · Cited by 20
“Some studies have reported higher abundance of Lactobacillus in gastrointestinal disorders and indicated that Lactobacillus could be used with caution as probiotics [36,37].”
BackgroundCharacteristics of Gut Microbiota in Cerulein-Induced Chronic Pancreatitis
Wu, C., Li, M., & Chen, W. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s291822 · Cited by 18
“Bifidobacterium was also found increased in active inflammatory bowel disease patients, and it may play a role in promoting inflammation.(26) However, the role of increased Bifidobacterium in CP is unclear.”
BackgroundZhao, H., Zhang, W., Cheng, D., You, L., Huang, Y., & Lu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1023896 · Cited by 19
Calzadilla, N., Qazi, A., Sharma, A., Mongan, K., Comiskey, S., Manne, J., Youkhana, A. G., Khanna, S., Saksena, S., Dudeja, P. K., et al. (2023) · Metabolites · doi:10.3390/metabo13070873 · Cited by 15
“There have also been reported increases in the genus Lactobacillus in IBD cohorts [37], which were also found in the chronic DSS samples (Figure 2C, p = 0.”
BackgroundResultGeng, Z.-H., Zhu, Y., Chen, W., Fu, P., Xu, J., Wang, T.-Y., Yao, L., Liu, Z., Li, X., Zhang, Z., et al. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127470 · Cited by 16
Metadata
- Authors
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 52
- Issue
- 2
- Pages
- 398-406
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3911339
- OpenAlex
- W2097788076
- Cited by
- 509
- References
- 48
- Citations by year
- 2026: 26 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 74 · 2021: 56 · 2020: 53 · 2019: 39 · 2018: 29 · 2017: 24 · 2016: 28 · 2015: 12 · 2014: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut dysbiosis, Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, butyrate-producing bacteria, mucosa-associated bacteria, fecal bacteria, probiotics, 16S rRNA gene
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Biopsy, Butyrates, Feces, Female, Humans, Intestinal Mucosa, Lactobacillus, Male, Middle Aged, RNA, Bacterial, RNA, Ribosomal, 16S, Inflammatory Bowel Diseases, Gastrointestinal Tract, Young Adult, Biota, Bacterial Load, Real-Time Polymerase Chain Reaction, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.